References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Bosetal(1997)PD153035,atyrosinekinaseinhibitor,preventsepidermalgrowthfactorreceptoractivationandinhibitsgrowthofcancercellsinareceptornumber-dependentmanner.Clin.CancerRes.32099PMID:9815602
Bridgesetal(1996)Tyrosinekinaseinhibitors.8.Anunusuallysteepstructure-activityrelationshipforanaloguesof4-(3-bromoanilino)-6,7-dimethoxyquinazoline(PD153035),apotentinhibitoroftheepidermalgrowthfactorreceptor.J.Med.Chem.39267PMID:8568816
Fryetal(1994)Aspecificinhibitoroftheepidermalgrowthfactorreceptortyrosinekinase.Science2651093PMID:8066447
Keywords:PD153035hydrochloride,supplier,EGFR-kinase,inhibitors,inhibits,Epidermal,Growth,Factors,Receptors,ErbB,Her,Receptor,Tyrosine,Kinases,RTKs,PD153035,hydrochloride,AstraZeneca,ZM252868,ZM,252868,EGFR,EGFR,TocrisBioscience